| Dr Carl Allen Thompson, DO | |
|
1011 14th Ave Nw, Ardmore, OK 73401-1828 | |
| (580) 220-6658 | |
| (580) 220-6673 |
| Full Name | Dr Carl Allen Thompson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1011 14th Ave Nw, Ardmore, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427256619 | NPI | - | NPPES |
| 200115280A | Medicaid | OK |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital Health Center | Syracuse, NY | Hospital |
| Mercy Hospital Ardmore, Inc | Ardmore, OK | Hospital |
| Medical City Plano | Plano, TX | Hospital |
| Navarro Regional Hospital | Corsicana, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Navarro Emergency Physicians Pllc | 1254487861 | 19 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Entity Name | Navarro Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851523252 PECOS PAC ID: 1254487861 Enrollment ID: O20090923000744 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Entity Name | 24 Hour Physicians, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396083424 PECOS PAC ID: 2365670486 Enrollment ID: O20140118000272 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Entity Name | Concord North Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952761173 PECOS PAC ID: 2860791688 Enrollment ID: O20160429000472 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carl Allen Thompson, DO 530 N Monte Vista St, Suite A, Ada, OK 74820-4675 Ph: (580) 436-7101 | Dr Carl Allen Thompson, DO 1011 14th Ave Nw, Ardmore, OK 73401-1828 Ph: (580) 220-6658 |
News Archive
ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.
Until a child's bones have fully matured (in girls, typically by age 14; in boys, age 16), an injury to the anterior cruciate ligament (ACL)-the primary, stabilizing ligament of the knee joint-requires special consideration, treatment and care to ensure appropriate healing and to prevent long-term complications.
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
› Verified 7 days ago
Mark Damon Ii, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Ernest Byron Foster Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Daniel Ryan Wheeler, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6588 | |
Lindsay Anne Wilson, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6132 Fax: 580-220-6772 | |
Daniel Francis Mckinley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-220-6658 Fax: 580-220-6673 | |
Dr. Jason Andrew Carter, MD, MHSA, FACEP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 4th Ave Nw Ste 96, Ardmore, OK 73401 Phone: 417-612-3985 |